OLAPARIB 50 mg Logo Pill: white, capsule/oblong
Generic Name: olaparib
The pill with imprint OLAPARIB 50 mg Logo (White, Capsule/Oblong, 0mm) has been identified as Lynparza 50 mg and is used for Ovarian Cancer, Prostate Cancer, Pancreatic Cancer, Breast Cancer, and Breast Cancer, Metastatic. It belongs to the drug class PARP inhibitors and is not a controlled substance.
Images for OLAPARIB 50 mg Logo
Lynparza
- Generic Name
- olaparib
- Imprint
- OLAPARIB 50 mg Logo
- Strength
- 50 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- PARP inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-0657 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
titanium dioxide,
shellac,
ferrosoferric oxide,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia
Note: Inactive ingredients may vary.
See also:
More about Lynparza (olaparib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.